Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 441-446

  Mori, Masaki ^a   Inoue, Hiroshi ^a   Shiraishi, Takeshi ^a   Mimori, Koshi ^a   Shibuta, Kenji ^a   Nakashima, Hideaki ^b   Mafune, Kenichi ^c   Tanaka, Youichi ^c   Ueo, Hiroaki ^d   Barnard, Graham F ^e   Sugimachi, Keizo ^b   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d OITA PREFECTURAL HOSPITAL   (Japan)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ARTICLE; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INSULIN-LIKE GROWTH FACTOR II; RNA, MESSENGER;

EID: 10544239103     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<441::AID-IJC7>3.0.CO;2-0     Document Type: Article

References (24)

1. BAKER, J., LIU, J.P., ROBERTSON, E.J. and EFSTRATIADIS, A., Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75, 73-82 (1993).
2. COUNTS, J.L. and GOODMAN, J.I., Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol. Carcinogen., 11, 185-188 (1994).
3. DECHIARA, T.M., EFSTRATIADIS, A., and ROBERTSON, E.J., A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (Land.), 345, 78-80 (1990).
4. EL-BADRY, O.M., MINNITE, C., KOHN, E.G., HOUOHTON, P.J., DAUGHA-DAY, W.H. and HELMAN, L.J., Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Diff., 1, 325-331 (1990).
5. GAMA-SOSA, M.A., WANG, R.Y., KUO, K.C., GEHRKE, C.W. and EHRLICH, M., The 5-methylcytosine content of DNA from human tumors. Nucl. Acids Res., 11, 6883-6894 (1983).
6. GLOUDEMANS, T., POSPIECH, I., LEO, T.M.V.D.V., CORNELIS, C.J.M., SCHNEID, H., WILLEM, D.O. and SUSSENBACH, S.S., Expression and CpG methylation of the insulin-like growth factor II gene in human smooth-muscle tumors. Cancer Res., 52, 6516-6521 (1992).
7. HASHIMOTO, K., AZUMA, C., KOYAMA, M., OHASHI, K., KAMIURA, S., NOBUNAGA, T., KIMURA, T., TOKUGAWA, Y., KANAI, T. and SAJI, F., Loss of imprinting in choriocarcinoma. Nature Genet., 9, 109-110 (1995).
8. JAPANESE SOCIETY FOR ESOPHAGEAL DISEASES. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jap. J. Surg., 6, 69-78 (1976).
9. LAMBERT, S., VIVARIO, J., BONIVER, J. and GOI-WINKLER, R., Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int. J. Cancer, 46, 405-410 (1990).
10. MACAULAY, V.M., Insulin-like growth factors and cancer. Brit. J. Cancer, 65, 311-320 (1992).
11. MORI, M., BARNARD, G.F., MIMORI, K., UEO, H., AKIYOSHI, T. and SUGIMACHI, K., Overexpression of matrix metalloproteinase 7 mRNA in human colon carcinomas. Cancer, 75, 1516-1519 (1995a).
12. MORI, M., BARNARD, G.F., STAINIUNAS, R.J., JESSUP, J.M., STEELE, G.D., JR. and CHEN, L.B., Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 8, 2821-2826 (1993).
13. MORI, M., MATSUKUMA, A., ADACHI, Y., MIYAGAHARA, T., MATSUDA, H., KUWANO, H., SUGIMACHI, K. and ENJOJI, M., Small cell carcinoma of the esophagus. Cancer, 63, 564-573 (1989).
14. MORI. M., MIMORI, K., INOUE, H., GRAHAM, G.F., TSUJI, K., NAN-BARA, S., UEO, H. and AKIYOSHI, T., Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 55, 3417-3720 (1995b).
15. OGAWA, O., ECCLES, M.R., SZETO, J., MCNOE, L.A., YUN, K., MAW, M.A., SMITH, P.J. and REEVE, A.E., Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (Land.), 362, 749-751 (1993).
16. RAINIER, S. and FEINBERG, A.P., Genomic imprinting, DNA methylation, and cancer. J. nAt. Cancer Inst., 144, 431-443 (1994).
17. STEENMAN, M.J.C., RAINIER, S., COBRY, C.J., GRUNDY, P., HORON, I.L. and FEINBERG, A.P., Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet., 7, 433-439 (1994).
18. SUZUKI, H., UEDA, R., TAKAHASHI, T. and TAKAHASHI, T., Altered imprinting in lung cancer. Nature Genet., 6, 332-333 (1994).
19. TADOKORO, K., FUJII, H., INDUE, T. and YAMADA, M., Polymerase chain reaction (PCR) for detection of Apal polymorphism at the insulin-like growth factor II gene (IGF2). Nucl. Acids Res., 19, 6967 (1991).
20. TRICOLI, J.V., RALL, L.B., KARAKOUSIS, C.P., HERRERA, L., PETRELLI, N.J., BELL, G.I. and SHOWS, T.B., Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res., 46, 6169-6173 (1986).
21. TYCKO, B., Genomic imprinting: mechanism and role in human pathology. Amer. J. Pathol., 144, 431-443 (1994).
22. VAN GURP, R.J.H.L.M., OOSTERHUIS, J.W., KALSCHEUER, V., MARIMAN, E.C.M. and LOOUENGA, L.H.J., Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J. nat. Cancer Inst., 86, 1070-1075 (1994).
23. YEE, D., CULLEN, K.J., PAIK, S., PERDUE, J.F., HAMPTON, B., SCHWARTZ, A., LIPPMAN, M.E. and ROSEN, N., Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res., 48, 6691-6696 (1988).
24. ZHAN, S., SHAPIRO, D.N. and HELMAN, L.J., Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. clin. Invest., 94, 445-448 (1994).